Search

Novocure Ltd

Chiusa

SettoreSettore sanitario

16.19 -0.43

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

15.9

Massimo

16.66

Metriche Chiave

By Trading Economics

Entrata

55M

-16M

Vendite

9.5M

184M

EPS

-0.13

Margine di Profitto

-8.529

Dipendenti

1,605

EBITDA

53M

-11M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+81.54% upside

Dividendi

By Acuity

Utili prossimi

29 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

79M

1.9B

Apertura precedente

16.62

Chiusura precedente

16.19

Notizie sul Sentiment di mercato

By Acuity

55%

45%

264 / 339 Classifica in Healthcare

Novocure Ltd Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 set 2026, 19:16 UTC

Novocure Ltd shares fell sharply, trading below their 20-day moving average and around the midpoint of their one-month trading range.

18 set 2026, 23:36 UTC

Novocure Ltd is trading modestly higher in after-market hours, recovering from a decline earlier in the day but remaining below its 20-day moving average.

17 set 2026, 19:51 UTC

Novocure Ltd is trading higher amid a broader market rally, boosted by strong labor market data and a positive Philadelphia Fed Manufacturing Index.

16 set 2026, 23:06 UTC

Novocure Ltd has gained modestly in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

15 set 2026, 19:26 UTC

Novocure Ltd. shares are advancing, rebounding from an earlier low, after three consecutive sessions of gains. The stock remains below its 20-day moving average.

14 set 2026, 20:21 UTC

Novocure Ltd shares are higher in after-market hours, continuing a trend of daily gains. No specific news was identified to explain the movement.

11 set 2026, 19:36 UTC

Novocure shares are trading higher, buoyed by positive sentiment in the health care equipment sector and broader market dynamics despite some volatility earlier in the session.

10 set 2026, 19:46 UTC

Novocure Ltd. shares are lower, continuing a three-session decline amid broader market pressure from the European Central Bank's interest rate hike and inflation warnings.

9 set 2026, 23:06 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a three-session decline and remaining below their 20-day moving average. No specific news was identified.

8 set 2026, 22:26 UTC

Shares of Novocure Ltd. are higher in after-market trading, fluctuating within a narrow range since Tuesday's close and remaining near the lower end of their one-month range.

2 set 2026, 20:08 UTC

News

Novocure Ltd is trading higher as it prepares for two investor events, including chats at the Wells Fargo and Morgan Stanley healthcare conferences.

1 set 2026, 19:11 UTC

News

Novocure Ltd shares are lower following a data breach affecting over 1,400 U.S. records, disclosed in a regulatory filing earlier today.

28 ago 2026, 20:07 UTC

Novocure Ltd. shares are lower today, pulled back from earlier gains amid rising U.S. Treasury yields impacting broader equity markets.

27 ago 2026, 22:01 UTC

Novocure Ltd. shares are lower in after-market hours, reversing a three-session upward trend and moving below the 20-day moving average.

26 ago 2026, 20:08 UTC

Novocure Ltd's shares are higher today, continuing an upward trend. The stock is trading above its 20-day moving average and near its one-month range high.

25 ago 2026, 20:07 UTC

Novocure Ltd shares are higher today, reversing three days of declines. Easing Treasury yields and lower oil prices have supported overall market sentiment.

24 ago 2026, 21:01 UTC

Novocure Ltd. shares are higher in after-market hours, continuing a positive move since Monday's close and trading above the 20-day moving average.

21 ago 2026, 23:41 UTC

In after-market trading, Novocure Ltd shares moved higher, reaching the upper end of their one-month trading range, 5.40% above the 20-day moving average.

20 ago 2026, 19:16 UTC

Novocure shares are lower today, having reached a session low earlier. No specific company news was identified to explain the decline.

19 ago 2026, 23:11 UTC

Novocure Ltd shares closed higher in after-market trading, recovering from earlier lows and finishing above their 20-day moving average. No specific news was identified.

17 ago 2026, 19:56 UTC

Novocure Ltd. shares are trading higher, rebounding from recent declines and remaining above the 20-day moving average, indicating a shift in momentum.

15 ago 2026, 00:01 UTC

Novocure Ltd. shares are higher in after-market trading, showing notable strength since Friday's close and currently above the 20-day moving average.

14 ago 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13 ago 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12 ago 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11 ago 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10 ago 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8 ago 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7 ago 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

6 ago 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

Confronto tra pari

Modifica del prezzo

Novocure Ltd Previsione

Obiettivo di Prezzo

By TipRanks

81.54% in crescita

Previsioni per 12 mesi

Media 29.5 USD  81.54%

Alto 52 USD

Basso 17 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Novocure Ltd - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Sentiment

By Acuity

264 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.